Parabilis Soared Biggest Biotech: Is It Too Late to Buy?
A record biotech IPO backdrop has investors buzzing about Parabilis Medicines. This guide breaks down what the surge ...
This tag page curates IPO coverage with four recent articles, from Klarna's plunge to Figma's rebound, helping you spot opportunities and manage risk in the evolving stock market.
443 articlesA record biotech IPO backdrop has investors buzzing about Parabilis Medicines. This guide breaks down what the surge ...
SpaceX is set to go public on NASDAQ this Friday, with analysts predicting a historic IPO. Markets monitor the offeri...
SpaceX plans a $135-per-share IPO that could push its value to $1.77 trillion, potentially the largest U.S. listing e...
The rumor of a SpaceX IPO is stirring chatter across Wall Street and Main Street alike. If true, spacex could trigger...
Robinhood just approval underwrite signals a bold pivot for the trading app. As SpaceX prepares for a blockbuster IPO...
SpaceX's upcoming IPO is drawing historic foreign demand, with offshore bids making up a large share of the book. Ana...
Crypto traders wager on SpaceX ahead of its Nasdaq debut, driving more than $1 billion in SPCX perpetual futures over...
SpaceX’s impending IPO is driving the launch of leveraged ETFs designed to amplify bets on the rocket company, offeri...
SpaceX is on the cusp of a potential $1.75 trillion IPO. This article explains how crypto platforms broaden access to...
A high-profile SpaceX IPO could unleash a broad wave of capex across aerospace, semiconductors, and industrial suppli...
SpaceX's move toward a public market future brings questions about lockups. This guide explains spacex lockup period:...
SpaceX's IPO hype is hard to ignore, but there are four solid concerns investors should weigh before buying in. This ...